← FDA DRUG APPROVALS

FDA NDA · NDA020111

CHLORHEXIDINE GLUCONATE SOLUTION 0.75% ANTISEPTIC

Sponsor: BAJAJ

APPLICATION
NDA020111
TYPE
NDA
ORIGINAL APPROVAL
1997-09-11
LATEST ACTION
2019-02-22
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

CHLORHEXIDINE GLUCONATEOver-the-counter
CHLORHEXIDINE GLUCONATE 0.75% · SOLUTION · TOPICAL

Approval history

2019-02-22Labeling · Supplement 13 · standardLetterAP
2017-11-20Labeling · Supplement 9 · standardLabelAP
2013-05-08Labeling · Supplement 7 · standardLabelAP
1999-10-08Manufacturing (CMC) · Supplement 2 · standardAP
1998-04-16Manufacturing (CMC) · Supplement 1 · standardAP
1997-09-11Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →